Stay updated on Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Deleted related topics: Melanoma and MedlinePlus Genetics from the page's topics section. This is a minor change that does not affect core trial information or how to participate; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-26T18:16:50.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Locations were updated with many new sites across the US and internationally, and several existing sites were removed.
    Difference
    3%
    Check dated 2025-12-19T12:34:53.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Removed related topics entries for Melanoma and MedlinePlus Genetics from the Related Topics section.
    Difference
    0.1%
    Check dated 2025-12-05T02:46:25.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Related topics Melanoma and MedlinePlus Genetics were added to the page, and the revision version was updated from v3.3.1 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-28T01:18:06.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Added a note that publications are automatically filled from PubMed. Updated the page revision to v3.3.1 and removed older PubMed-related wording (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-20T22:09:18.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    Removal of the government funding status banner; the page's study content and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-13T15:42:36.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Ipilimumab in Melanoma Recurrence Prevention Clinical Trial page.